COMMUNIQUÉS West-GlobeNewswire

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

07/02/2025 - 14:00

DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

07/02/2025 - 14:06

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an increase in accidental drug-related deaths year over year The ‘Lay, Spray, Stay [...]

Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study

07/02/2025 - 14:21

DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”) , developer of the AI-driven DeepView ® System, which received Breakthrough Device Designation from the U.S. Food and [...]

Ascentage Pharma Announces Partial Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

07/02/2025 - 14:24

ROCKVILLE, Md. and SUZHOU, China, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG, HKEX: 6855) announced today that the underwriters of its underwritten U.S. initial public offering (the “Offering”) [...]

Safety Shot, Inc. Secures Significant Order from Leading Midwestern Grocer, Underscoring Growing Consumer and Retailer Confidence in Sure Shot Brand

07/02/2025 - 14:30

SCOTTSDALE, Ariz., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or the "Company"), a leading wellness and dietary supplement company, today announced a significant order for its [...]

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

07/02/2025 - 14:30

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities TNX-102 SL [...]

Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch

07/02/2025 - 14:30

Avon Freight Group selects INBS’ fingerprint drug testing for three UK sites, reinforcing workplace safety and efficiency INBS surpasses 400+ accounts in 19 countries, targeting aggressive U.S. expansion in 2025 [...]

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

07/02/2025 - 14:30

FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious [...]

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

07/02/2025 - 14:50

Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of Ampligen as an intranasal adjuvant increased immune response, including [...]

Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.

07/02/2025 - 15:15

Current Board’s Strategic, Management, and Capital Allocation Failures Have Driven an 80% Stock Decline Over Last 22 Months New Leadership is Urgently Needed to Restore Accountability in the Boardroom Restore Value [...]

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

07/02/2025 - 16:00

Patient treated in procedure, conducted at Mass General Transplant Center and in collaboration with partner eGenesis, was recently released from hospital Investigational therapy tegoprubart targets CD40 ligand (CD40L) [...]

Carla da Luz Boren Recognized Among Top 50 Women Leaders in Healthcare Technology

07/02/2025 - 16:18

WESTWOOD, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical announced that Carla da Luz Boren, J.D., the Company’s chief human resources officer, has been named among the Top 50 Women Leaders in Healthcare [...]

Le CMUH recommande RYBREVANT®▼ (amivantamab) par voie sous-cutanée dans le cadre du traitement des patients atteints d’un cancer du poumon non à petites cellules avancé avec mutations de l’EGFR

07/02/2025 - 17:35

Les données issues de l’étude de Phase 3 PALOMA-3 ont révélé une non-infériorité par rapport à l’administration intraveineuse pour les deux co-critères d’évaluation pharmacocinétiques principaux, ainsi qu’une division [...]

OHC - Ford government’s primary care announcement plays politics with people’s need for a family doctor: It’s a primary care “plan” to implement a plan delayed until the cusp of an election

07/02/2025 - 18:44

TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- No matter how anyone tries to spin the numbers, the actual data from sources not tainted by politics, show that more than a million Ontarians have lost their family doctor [...]

WAKE RADIOLOGY PROMOTES HEART HEALTH WITH ADVANCED IMAGING SERVICES AND SCREENINGS DURING FEBRUARY

07/02/2025 - 18:52

Raleigh, N.C., Feb. 07, 2025 (GLOBE NEWSWIRE) -- This National Wear Red Day, Wake Radiology is raising awareness for heart health by offering advanced cardiac imaging services and encouraging participation in Heart [...]

Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure

07/02/2025 - 20:56

WARREN, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, met the Center for the Biomedical [...]

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

07/02/2025 - 21:22

BOCA RATON, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non- [...]

Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period

07/02/2025 - 22:00

This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and [...]

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07/02/2025 - 22:01

NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]